Effect on Ocular Surface Symptoms of Online Education

Sponsor
Kahramanmaras Sutcu Imam University (Other)
Overall Status
Completed
CT.gov ID
NCT04960696
Collaborator
(none)
315
1
2.2
143.1

Study Details

Study Description

Brief Summary

retrospective, observational study.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: OSDI
  • Diagnostic Test: tear break up time
  • Diagnostic Test: schirmer

Detailed Description

Aim: The aim of this study was to investigate the effects on ocular surface symptoms of students taking online education, which was a part of the distance learning model during the COVID-19 pandemic, to be able to prevent the formation of irreversible damage with early diagnosis and treatment. With recommendations that can be simply applied, it was aimed to protect ocular health.

Material and Method: The study included 315 students who were undertaking online education and presented at the Ophthalmology Department of a tertiary level university hospital. A record was made of sociodemographic data, Schirmer test results, tear break-up time (TBUT) measurements, and Ocular Surface Disease Index (OSDI) scores. The data were analyzed statistically using SPSS vn. 22.0 software, and a value of p<0.05 was accepted as statistically significant.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
315 participants
Observational Model:
Ecologic or Community
Time Perspective:
Other
Official Title:
An Evaluation of the Effect on Ocular Surface Symptoms of Online Education During the Pandemic
Actual Study Start Date :
Apr 14, 2021
Actual Primary Completion Date :
Jun 15, 2021
Actual Study Completion Date :
Jun 20, 2021

Arms and Interventions

Arm Intervention/Treatment
primary school/78 subjects

Determining the negative effects of distance education on eye symptoms during the pandemic period.

Diagnostic Test: OSDI
Change of OSDI in distance education

Diagnostic Test: tear break up time
Change of tear break up time in distance education

Diagnostic Test: schirmer
Change of schirmer in distance education

middle school/78 subjects

Determining the negative effects of distance education on eye symptoms during the pandemic period.

Diagnostic Test: OSDI
Change of OSDI in distance education

Diagnostic Test: tear break up time
Change of tear break up time in distance education

Diagnostic Test: schirmer
Change of schirmer in distance education

high school/78 subjects

Determining the negative effects of distance education on eye symptoms during the pandemic period.

Diagnostic Test: OSDI
Change of OSDI in distance education

Diagnostic Test: tear break up time
Change of tear break up time in distance education

Diagnostic Test: schirmer
Change of schirmer in distance education

university/81 subjects

Determining the negative effects of distance education on eye symptoms during the pandemic period.

Diagnostic Test: OSDI
Change of OSDI in distance education

Diagnostic Test: tear break up time
Change of tear break up time in distance education

Diagnostic Test: schirmer
Change of schirmer in distance education

Outcome Measures

Primary Outcome Measures

  1. Dry eye symptom scale: ocular symptom scale index (OSDI) [baseline]

    Change of OSDI in distance education

  2. Dry eye symptom scale:Tear break up time (TBUT) [baseline]

    Change of tear break up time in distance education

  3. Dry eye scale:Schirmer [baseline]

    Change of Schirmer in distance education

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 30 Years
Sexes Eligible for Study:
All
Inclusion Criteria:

Online education >6 years <30 years student

Exclusion Criteria:

not student not taking online education <6 years >30 years

Contacts and Locations

Locations

Site City State Country Postal Code
1 Abdullah Beyoğlu Kahramanmaraş In The USA Or Canada, Please Select... Turkey 46040

Sponsors and Collaborators

  • Kahramanmaras Sutcu Imam University

Investigators

  • Study Chair: Abdullah Beyoğlu, Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Abdullah Beyoğlu, Assist of Prof, Kahramanmaras Sutcu Imam University
ClinicalTrials.gov Identifier:
NCT04960696
Other Study ID Numbers:
  • desicion:06, dated: 12/04/21
First Posted:
Jul 14, 2021
Last Update Posted:
Jul 14, 2021
Last Verified:
Jul 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Abdullah Beyoğlu, Assist of Prof, Kahramanmaras Sutcu Imam University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 14, 2021